Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Energy Fuels Aktie: Achtung, Aufholpotenzial! (Aktiencheck) +++ ENERGY FUELS Aktie -3,11%

HEMOSTEMIX Aktie

 >HEMOSTEMIX Aktienkurs 
0.085 EUR    -7.1%    (Tradegate)
Ask: 0.096 EUR / 32000 Stück
Bid: 0.085 EUR / 36000 Stück
Tagesumsatz: 10000 Stück
Realtime Kurs von 8 bis 22 Uhr!
HEMOSTEMIX Aktie über LYNX handeln
>HEMOSTEMIX Performance
1 Woche: +7,7%
1 Monat: +18,5%
3 Monate: +45,4%
6 Monate: +204,2%
1 Jahr: +189,7%
laufendes Jahr: +204,2%
>HEMOSTEMIX Aktie
Name:  HEMOSTEMIX INC.
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA4236943060 / A2QQGU
Symbol/ Ticker:  2VF0 (Frankfurt)
Kürzel:  FRA:2VF0, ETR:2VF0, 2VF0:GR
Index:  -
Webseite:  https://hemostemix.com/
Marktkapitalisierung:  10.67 Mio. EUR
Umsatz:  -
EBITDA:  -2.3 Mio. EUR
Gewinn je Aktie:  -0.018 EUR
Schulden:  4.12 Mio. EUR
Liquide Mittel:  0.85 Mio. EUR
Umsatz-/ Gewinnwachstum:  - / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  - / - / -
Gewinnm./ Eigenkapitalr.:  - / -
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  HEMOSTEMIX
Letzte Datenerhebung:  04.07.25
>HEMOSTEMIX Eigentümer
Aktien: 145.31 Mio. St.
f.h. Aktien: 83.12 Mio. St.
Insider Eigner: 11.17%
Instit. Eigner: -
Leerverk. Aktien: -
>HEMOSTEMIX Peer Group

 
04.07.25 - 14:36
Hemostemix Inc.: Hemostemix Closes $469,366 Private Placement (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - July 4, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") announces that the TSX Venture Exchange ("TSXV") conditio......
03.07.25 - 16:36
Hemostemix Inc.: Hemostemix Announces its 10th Publication: A Molecular Strategy for the Treatment of Heart Failure: Response to BioCardia′s Cardiamp Heart Failure Trial (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - July 3, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is proud to share the Journal of Biomedical Research and Environmental Science published ......
02.07.25 - 09:06
Hemostemix Inc.: Hemostemix′s VesCell Sales are Legal in Florida as it Pivots to Allow Non-FDA Approved Stem Cell Treatments! (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - July 2, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), a clinical-stage biotechnology company focused on autologous stem cell therapies for car......
27.06.25 - 18:06
Hemostemix Inc.: Croom Lawrence Joins Hemostemix with Revenue Share Agreement and VesCell.Health Launch (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - June 27, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF), a leading Phase III autologous stem cell therapy company and Mr. Croom Lawrence are pleased to anno......
26.06.25 - 15:06
Hemostemix Inc.: Hemostemix Announces Lead Order of $1,500,000 and the Full Repayment of $2,500,000 Convertible Debenture (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - June 26, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") announces its Chairman, Peter Lacey, has provided the Co......
17.06.25 - 15:01
Hemostemix Inc.: Hemostemix Closes Private Placement of $469,366 (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - June 17, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") announces the closing of a non brokered private placemen......
20.05.25 - 15:06
Hemostemix Inc.: Hemostemix Presents at TERMIS 2025, Freiburg, Germany (Newsfile)
 
Freiburg, Germany--(Newsfile Corp. - May 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF), a leading Phase III clinical-stage biotechnology company developing autologous stem cell therapies ......
12.05.25 - 15:06
Hemostemix Inc.: Hemostemix Closes Private Placement of USD $336,500 at $0.295 per Share (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - May 12, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"), per the Company's February 4, 2025 news release, closed ......
08.05.25 - 15:18
Hemostemix Inc.: Hemostemix at Invest Stuttgart (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - May 8, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is poised to make a significant impact at Invest Stuttgart......
23.04.25 - 18:06
Hemostemix Inc.: Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - April 23, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) a leader in the development of autologous stem cell therapy for the treatment of cardio......
17.03.25 - 15:48
Hemostemix Inc.: Hemostemix′s Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - March 17, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely tre......
06.03.25 - 13:42
Hemostemix Inc.: Hemostemix and FireFly Neuroscience′s Brain Network Analytics (BNA) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01 (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely trea......
05.03.25 - 13:54
Hemostemix Inc.: Hemostemix Sells Its 23rd ACP-01 Therapy Convertible Debenture (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - March 5, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell therapy company that has saf......
19.02.25 - 21:30
Hemostemix Inc.: Hemostemix Licenses CytoImmune′s BioReactor Technologies (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - February 19, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is delighted to announce a strategic breakthrough th......
14.02.25 - 02:18
Hemostemix Inc.: Hemostemix Provides Corporate Update (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - February 13, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") announces that, at the request of the Canadian Inves......
11.02.25 - 16:00
Hemostemix Inc.: Hemostemix PR Inc. Congratulates Luis Munoz Marin International Airport on Achieving CEIV Pharma Certification (Newsfile)
 
San Juan, Puerto Rico--(Newsfile Corp. - February 11, 2025) - Hemostemix PR Inc. proudly congratulates Luis Muñoz Marín International Airport (SJU) on achieving the prestigious CEIV Pharma Certifi......
10.02.25 - 16:54
Hemostemix Inc.: Hemostemix Contracts ProConsul to Ramp up Engagement with New Investors (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - February 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is excited to announce that it has engaged ProConsul......
04.02.25 - 23:30
Hemostemix Inc.: CytoImmune Subscribes for 1,634,466 Hemostemix Common Shares (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - February 4, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is delighted to announce that CytoImmune is subscribing......
03.02.25 - 19:12
Hemostemix Inc.: Hemostemix Expands to the Dominican Republic (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - February 3, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce its continued expansion, as the ......
29.01.25 - 20:18
Hemostemix Inc.: Hemostemix Announces First Sales Orders for ACP-01 (Newsfile)
 
Calgary, Alberta--(Newsfile Corp. - January 29, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is very pleased to announce that its sales of ACP-01 Tr......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Im Winter beim Ofen, im Sommer im Feld. - Bauernregel - Bauernweisheit
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!